Literature DB >> 26306687

Myeloradiculopathy associated with chikungunya virus infection.

Anna M Bank1,2,3, Ayush Batra4,5,6, Rene A Colorado4,5,6, Jennifer L Lyons4,6.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that is endemic to parts of Africa, South and Southeast Asia, and more recently the Caribbean. Patients typically present with fever, rash, and arthralgias, though neurologic symptoms, primarily encephalitis, have been described. We report the case of a 47-year-old woman who was clinically diagnosed with CHIKV while traveling in the Dominican Republic and presented 10 days later with left lower extremity weakness, a corresponding enhancing thoracic spinal cord lesion, and positive CHIKV serologies. She initially responded to corticosteroids, followed by relapsing symptoms and gradual clinical improvement. The time lapse between acute CHIKV infection and the onset of myelopathic sequelae suggests an immune-mediated phenomenon rather than direct activity of the virus itself. Chikungunya virus should be considered in the differential diagnosis of myelopathy in endemic areas. The progression of symptoms despite corticosteroid administration suggests more aggressive immunomodulatory therapies may be warranted at disease onset.

Entities:  

Keywords:  Chikungunya; Infectious myelopathy; Myelopathy; Viral myelopathy

Mesh:

Substances:

Year:  2015        PMID: 26306687     DOI: 10.1007/s13365-015-0372-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  17 in total

1.  VIROLOGICAL INVESTIGATION OF THE EPIDEMIC OF HAEMORRHAGIC FEVER IN CALCUTTA: ISOLATION OF THREE STRAINS OF CHIKUNGUNYA VIRUS.

Authors:  K V SHAH; C J GIBBS; G BANERJEE
Journal:  Indian J Med Res       Date:  1964-07       Impact factor: 2.375

2.  Case reports of neuro-Chikungunya in southern Thailand.

Authors:  Sarunyou Chusri; Pisud Siripaitoon; Siriporn Hirunpat; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  Case of ADEM following Chikungunya fever.

Authors:  A K Mohamed Musthafa; P Abdurahiman; James Jose
Journal:  J Assoc Physicians India       Date:  2008-06

4.  Post chikungunya brain stem encephalitis.

Authors:  L A Gauri; B L Ranwa; K Nagar; A Vyas; Q Fatima
Journal:  J Assoc Physicians India       Date:  2012-04

5.  Chikungunya virus infection amongst the acute encephalitis syndrome cases in West Bengal, India.

Authors:  D Taraphdar; B K Roy; S Chatterjee
Journal:  Indian J Med Microbiol       Date:  2015-02       Impact factor: 0.985

6.  Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.

Authors:  Gianandrea Borgherini; Patrice Poubeau; Frederik Staikowsky; Manuella Lory; Nathalie Le Moullec; Jean Philippe Becquart; Catherine Wengling; Alain Michault; Fabrice Paganin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

7.  An essential role of antibodies in the control of Chikungunya virus infection.

Authors:  Fok-Moon Lum; Teck-Hui Teo; Wendy W L Lee; Yiu-Wing Kam; Laurent Rénia; Lisa F P Ng
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

8.  Neurological complications of Chikungunya virus infection.

Authors:  Nitin H Chandak; Rajpal S Kashyap; Dinesh Kabra; Poornima Karandikar; Sonali S Saha; Shweta H Morey; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Neurol India       Date:  2009 Mar-Apr       Impact factor: 2.117

9.  Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006.

Authors:  Marcus Panning; Klaus Grywna; Marjan van Esbroeck; Petra Emmerich; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

10.  IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.

Authors:  Lisa F P Ng; Angela Chow; Yong-Jiang Sun; Dyan J C Kwek; Poh-Lian Lim; Frederico Dimatatac; Lee-Ching Ng; Eng-Eong Ooi; Khar-Heng Choo; Zhisheng Her; Philippe Kourilsky; Yee-Sin Leo
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more
  9 in total

Review 1.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

2.  Chikungunya and Myositis: A Case Report in Brazil.

Authors:  Hugo Andre Martins; Silvya Nery Bernardino; Camila Cordeiro Santos; Valdenilson Ribeiro Ribas
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Case Report: Post-Chikungunya-Associated Myeloneuropathy.

Authors:  Ameya Patwardhan; Atchayaram Nalini; Priyanka Priyadarshini Baishya; Karthik Kulanthaivelu; Haripriya Krishnareddy; Debayan Dutta; Tanushree Chawla; Ravindranadh Mundlamuri Chowdary; Ravi Yadav; Seena Vengalil
Journal:  Am J Trop Med Hyg       Date:  2021-08-23       Impact factor: 3.707

Review 4.  Emerging Causes of Arbovirus Encephalitis in North America: Powassan, Chikungunya, and Zika Viruses.

Authors:  Christopher T Doughty; Sigal Yawetz; Jennifer Lyons
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 6.030

Review 5.  Neurologic Manifestation of Chikungunya Virus.

Authors:  Kate Brizzi
Journal:  Curr Infect Dis Rep       Date:  2017-02       Impact factor: 3.663

6.  Peripheral polyneuropathy associated with Chikungunya virus infection.

Authors:  Vanessa P Silva; Dacylla S Costa; Vania C C V L Carvalho; Tereza C C S Garcês; Emanuela L T Barros; Jefferson S Oliveira; Anna C T C Pereira; Gustavo P Ferreira
Journal:  J Neurovirol       Date:  2019-08-19       Impact factor: 3.739

Review 7.  The neurological complications of chikungunya virus: A systematic review.

Authors:  Ravi Mehta; Patrick Gerardin; Carlos Alexandre Antunes de Brito; Cristiane Nascimento Soares; Maria Lucia Brito Ferreira; Tom Solomon
Journal:  Rev Med Virol       Date:  2018-04-19       Impact factor: 6.989

8.  Zika might not be acting alone: Using an ecological study approach to investigate potential co-acting risk factors for an unusual pattern of microcephaly in Brazil.

Authors:  Monica C Campos; Jamille G Dombrowski; Jody Phelan; Claudio R F Marinho; Martin Hibberd; Taane G Clark; Susana Campino
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

Review 9.  Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.

Authors:  Nadine Attal; Valéria Martinez; Didier Bouhassira
Journal:  Pain Rep       Date:  2021-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.